Literature DB >> 25892497

Hydroxypropyl cellulose as an option for supplementation of cryoprotectant solutions for embryo vitrification in human assisted reproductive technologies.

Chiemi Mori1, Akiko Yabuuchi2, Kenji Ezoe1, Nana Murata1, Yuko Takayama1, Tadashi Okimura1, Kazuo Uchiyama1, Kei Takakura3, Hiroyuki Abe3, Keiko Wada1, Takashi Okuno1, Tamotsu Kobayashi1, Keiichi Kato4.   

Abstract

Hydroxypropyl cellulose (HPC) was investigated as a replacement for serum substitute supplement (SSS) for use in cryoprotectant solutions for embryo vitrification. Mouse blastocysts from inbred (n = 1056), hybrid (n = 128) strains, and 121 vitrified blastocysts donated by infertile patients (n = 102) were used. Mouse and human blastocysts, with or without zona pellucida, were vitrified and warmed in either 1% or 5% HPC or in 5% or 20% SSS-supplemented media using the Cryotop (Kitazato BioPharma Co. Ltd, Fuji, Japan) method, and the survival and oxygen consumption rates were assessed. Viscosity of each vitrification solution was compared. Survival rates of mouse hybrid blastocysts and human zona pellucida-intact blastocysts were comparable among the groups. Mouse and human zona pellucida-free blastocysts, which normally exhibit poor cryoresistance, showed significantly higher survival rates in 5% HPC than 5% SSS (P < 0.05). The 5% HPC-supplemented vitrification solution showed a significantly higher viscosity (P < 0.05). The blastocysts were easily detached from the Cryotop strip during warming when HPC-supplemented vitrification solution was used. The oxygen consumption rates were similar between non-vitrified and 5% HPC groups. The results suggest possible use of HPC for supplementation of cryoprotectant solutions and provide useful information to improve vitrification protocols.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cryotop®; embryo; hydroxypropyl cellulose; vitrification

Mesh:

Substances:

Year:  2015        PMID: 25892497     DOI: 10.1016/j.rbmo.2015.02.004

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  18 in total

1.  Hydroxypropyl cellulose supplementation in vitrification solutions: a prospective study with donor oocytes.

Authors:  Miguel Gallardo; María Hebles; Beatriz Migueles; Mónica Dorado; Laura Aguilera; Mercedes González; Paloma Piqueras; Alejandro Lucas; Lorena Montero; Pascual Sánchez-Martín; Fernando Sánchez-Martín; Ramón Risco
Journal:  J Assist Reprod Genet       Date:  2016-12-27       Impact factor: 3.412

2.  A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human oocytes: a retrospective cohort study.

Authors:  Aila Coello; Pilar Campos; José Remohí; Marcos Meseguer; Ana Cobo
Journal:  J Assist Reprod Genet       Date:  2016-01-11       Impact factor: 3.412

3.  "Universal Warming" protocol for vitrified oocytes to streamline cell exchange for transnational donation programs: a multi-center study.

Authors:  Lodovico Parmegiani; M G Minasi; A Arnone; V Casciani; G E Cognigni; R Viñoles; M T Varricchio; L A Quintero; E Greco; M Filicori
Journal:  J Assist Reprod Genet       Date:  2020-05-03       Impact factor: 3.412

Review 4.  Vitrification of embryos and oocytes for fertility preservation in cancer patients.

Authors:  Keiichi Kato
Journal:  Reprod Med Biol       Date:  2016-02-29

5.  Spatiotemporal perturbations of pronuclear breakdown preceding syngamy affect early human embryo development: a retrospective observational study.

Authors:  Kenji Ezoe; Giovanni Coticchio; Hitomi Takenouchi; Shota Taoda; Shima Namerikawa; Kasumi Honda; Tetsuya Miki; Tadashi Okimura; Tamotsu Kobayashi; Andrea Borini; Keiichi Kato
Journal:  J Assist Reprod Genet       Date:  2021-10-12       Impact factor: 3.412

6.  Maternal and obstetric outcomes are influenced by developmental stage and cryopreservation of transferred embryos after clomiphene citrate-based minimal stimulation IVF.

Authors:  Sachie Onogi; Kenji Ezoe; Nami Kawasaki; Hiroko Hayashi; Tomoko Kuroda; Kazumi Takeshima; Kaou Tanoue; Shogo Nishii; Keiichi Kato
Journal:  Hum Reprod Open       Date:  2022-04-08

7.  Effect of equilibration time on clinical and neonatal outcomes in human blastocysts vitrification.

Authors:  Shingo Mitsuhata; Momoko Hayashi; Yoshitaka Fujii; Hiroaki Motoyama; Yuji Endo
Journal:  Reprod Med Biol       Date:  2020-05-08

8.  Establishment of day 7 blastocyst freezing criteria using blastocyst diameter for single vitrified-warmed blastocyst transfer from live birth outcomes: a single-center, large cohort, retrospectively matched study.

Authors:  Satoshi Ueno; Kazuo Uchiyama; Tomoko Kuroda; Tadashi Okimura; Akiko Yabuuchi; Tamotsu Kobayashi; Keiichi Kato
Journal:  J Assist Reprod Genet       Date:  2020-07-21       Impact factor: 3.412

9.  Comparing prediction of ongoing pregnancy and live birth outcomes in patients with advanced and younger maternal age patients using KIDScore™ day 5: a large-cohort retrospective study with single vitrified-warmed blastocyst transfer.

Authors:  Keiichi Kato; Satoshi Ueno; Jørgen Berntsen; Motoki Ito; Kiyoe Shimazaki; Kazuo Uchiyama; Tadashi Okimura
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

10.  Testing the efficacy and efficiency of a single "universal warming protocol" for vitrified human embryos: prospective randomized controlled trial and retrospective longitudinal cohort study.

Authors:  L Parmegiani; K H Beilby; A Arnone; S Bernardi; A M Maccarini; E Nardi; G E Cognigni; M Filicori
Journal:  J Assist Reprod Genet       Date:  2018-08-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.